Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.3K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.3K
Overview of Exosomes01:36

Overview of Exosomes

3.3K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.3K
MicroRNAs01:22

MicroRNAs

3.5K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

23.6K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Expansion, functional diversification, and gene fusion events in the Ato protein family.

iScience·2026
Same author

Artificial Intelligence and Robotics in General Surgery: Opportunities and Challenges.

Cureus·2026
Same author

The Global Burden of Aortic Aneurysm and Its Attributable Risk Factors, 1990-2021: Results from the Global Burden of Disease Study 2021.

Health science reports·2026
Same author

The global burden of rheumatic heart disease: 1990-2021.

Clinical medicine (London, England)·2026
Same author

Preparation and Optimization of Voriconazole Gel 0.25% for Topical Delivery in Terbinafine Resistance Dermatophytosis: In Vitro and Pilot Animal Study.

Dermatology research and practice·2026
Same author

Design and evaluation of a gamified mobile application for teaching cardiac rhythm interpretation to nursing students: a quasi-experimental pre-post study.

BMC medical education·2026

Related Experiment Video

Updated: Dec 9, 2025

Isolating, Sequencing and Analyzing Extracellular MicroRNAs from Human Mesenchymal Stem Cells
10:55

Isolating, Sequencing and Analyzing Extracellular MicroRNAs from Human Mesenchymal Stem Cells

Published on: March 8, 2019

8.5K

Exosomal microRNAs derived from mesenchymal stem cells: cell-to-cell messages.

Kasra Asgarpour1, Zahra Shojaei2, Fatemeh Amiri3

  • 1Department of Medicine, University of Western Ontario, London, Ontario, Canada.

Cell Communication and Signaling : CCS
|September 12, 2020
PubMed
Summary

Mesenchymal stem cell (MSC)-derived exosomes carrying microRNAs (miRNAs) show promise for disease diagnosis and treatment, offering an alternative to MSCs due to safety concerns. These exosomal miRNAs could revolutionize disease management.

Keywords:
ExosomesMesenchymal stem cellsMicroRNA

More Related Videos

Setting a Successful Sorting for Extracellular Vesicle Isolation
08:37

Setting a Successful Sorting for Extracellular Vesicle Isolation

Published on: October 11, 2024

1.5K
Isolation, Characterization and MicroRNA-based Genetic Modification of Human Dental Follicle Stem Cells
07:56

Isolation, Characterization and MicroRNA-based Genetic Modification of Human Dental Follicle Stem Cells

Published on: November 16, 2018

7.1K

Related Experiment Videos

Last Updated: Dec 9, 2025

Isolating, Sequencing and Analyzing Extracellular MicroRNAs from Human Mesenchymal Stem Cells
10:55

Isolating, Sequencing and Analyzing Extracellular MicroRNAs from Human Mesenchymal Stem Cells

Published on: March 8, 2019

8.5K
Setting a Successful Sorting for Extracellular Vesicle Isolation
08:37

Setting a Successful Sorting for Extracellular Vesicle Isolation

Published on: October 11, 2024

1.5K
Isolation, Characterization and MicroRNA-based Genetic Modification of Human Dental Follicle Stem Cells
07:56

Isolation, Characterization and MicroRNA-based Genetic Modification of Human Dental Follicle Stem Cells

Published on: November 16, 2018

7.1K

Area of Science:

  • Biomedical Sciences
  • Cell Biology
  • Regenerative Medicine

Background:

  • Exosomes are extracellular vesicles with diverse biological roles.
  • Mesenchymal stem cells (MSCs) possess regenerative and immunomodulatory properties.
  • MSC use is limited by tumor-related concerns, necessitating alternative therapeutic strategies.

Purpose of the Study:

  • To explore the role of exosomal microRNAs (miRNAs) from MSCs.
  • To discuss their potential in disease progression, diagnosis, and treatment.
  • To highlight exosomal miRNAs as safer alternatives to intact MSCs.

Main Methods:

  • Review and discussion of existing literature on MSC-derived exosomes and miRNAs.
  • Analysis of exosomal miRNA content and function in various disease contexts.
  • Comparison of MSC-derived exosomes with intact MSCs for therapeutic applications.

Main Results:

  • Exosomes derived from MSCs are rich in specific miRNAs.
  • These exosomal miRNAs are implicated in disease progression and can serve as biomarkers.
  • MSC-derived exosomal miRNAs offer potential therapeutic benefits with reduced risks compared to MSCs.

Conclusions:

  • MSC-derived exosomal miRNAs represent a promising avenue for disease diagnosis and monitoring.
  • They offer a safer and more practical alternative to MSC transplantation for therapeutic interventions.
  • Further research into exosomal miRNA cargo and function can unlock novel treatment strategies.